Drug Pipeline

mFOLFOX Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04495088 Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With… Rectal Cancer Recruiting
Phase 2
NCT07176312 Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive… Gastroesophageal Adenocarcinoma Recruiting
Phase 1
NCT05458219 A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or… Locally Advanced Unresectable or Metastatic Solid Tumors Recruiting
Sponsors Running mFOLFOX Trials
Ralf Hofheinz (1) Innovent Biologics (Suzhou) Co. Ltd. (1) Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)
Disease Areas
Colorectal Cancer (1) Gastric Cancer (1)
Get alerts when mFOLFOX trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free